Clinical Trial Update: Bimatoprost as a Treatment for Graves' Orbitopathy [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 trial from Johns Hopkins University is evaluating bimatoprost as a treatment for Graves' ophthalmopathy and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Ophthalmopathy

Drugs mentioned

• Bimatoprost (bimatoprost)

Snippet

Sponsor: Johns Hopkins University | Conditions: Graves Ophthalmopathy | EARLY_Phase 1 | Status: RECRUITING